Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

Is there a role for molecular markers predicting the best chemotherapy to use in lung cancer?
gracevideo
Mon, 06/10/2013 - 06:00
Author
GRACE Videos and Articles

Drs. Nate Pennell, Mary Pinder, and Jack West discuss trials presented at ASCO 2013 testing the potential value of molecular marker testing to select optimal chemo for advanced non-small cell lung cancer (NSCLC).

[powerpress]

Discuss this post in the GRACE Discussion Forums

Tags
BRCA-1
BRCA1
Cleveland Clinic
ERCC-1
ERCC1
Gerold Bepler
Howard Jack West
Howard West
Jack West
MADeIT
Mary Pinder
Mary Pinder-Schenck
Moffitt Cancer Center
Molecular Oncology
Nate Pennell
Nathan Pennell
RAP-80
RAP80
RRM-1
RRM1
SLCG
Spanish Lung Cancer Group
Swedish Cancer Institute

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

Targeted Therapies Forum presented in English
Targeted Therapies Forum Presented in English 2023 Video Series 4
Video
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins. To watch the complete playlist click here.
Targeted Therapies Forum presented in English
Targeted Therapies Forum Presented in English 2023 Video Series 3
Video
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins. To watch the complete playlist click here.
Targeted Therapies Forum presented in English
Targeted Therapies Forum Presented in English 2023 Video Series 2
Video
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins. To watch the complete playlist click here.

Forum Discussions

OncTalk2023 Is Now Available on Demand
Blood Cancer ONCTalk 2023 Saturday, September 23, 2023 8:00 AM Pacific

ONKTALK is tomorrow. 

I hope to see you there.

Blood Cancer ONCTalk 2023 Saturday, September 23, 2023 8:00 AM Pacific

The forum is now available on demand here.  Don't hesitate to ask questions as they come up. 

Take care,

Janine

Multiple EGFR mutation lung cancer

Hi happybluesun,  Welcome to Grace.   I'm sorry your mom is going through this. 

 

Driver mutations are mutations that drive (or cause) the cancer.  Having more than one driver mutation is...

Multiple EGFR mutation lung cancer
Hi Janine, thank you very much for your reply. As of June 2023, my mom has been prescribed Almonertibi Mesilate Tablet, a targeted therapy medicine made by the Chinese company Haosen...
Multiple EGFR mutation lung cancer

Hi happybluesun, How is your mom feeling?  Her case has specific components including the rare combo of mutations situation we can't help with a specific "this is standard of care".  She...

Multiple EGFR mutation lung cancer
I agree with you that we should explore all possible TKI options before switching to another one. When you mention 'TKI options,' are you referring to various brands produced by different...

Recent Comments

JOIN THE CONVERSATION
Blood Cancer ONCTalk 2023 Saturday, September 23, 2023 8:00 AM Pacific
The forum is now available…
By JanineT GRACE … on Mon, 09/25/2023 - 14:10
Blood Cancer ONCTalk 2023 Saturday, September 23, 2023 8:00 AM Pacific
Reminder
By JanineT GRACE … on Fri, 09/22/2023 - 15:50
Multiple EGFR mutation lung cancer
Yes, all of the brand-named…
By JanineT GRACE … on Sun, 09/17/2023 - 14:43
Multiple EGFR mutation lung cancer
TKI options
By happybluesun on Sun, 09/17/2023 - 10:55